Huttenhower, C. et al. Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214 (2012).
Durack, J. & Lynch, S. V. The gut microbiome: relationships with disease and opportunities for therapy. J. Exp. Med. 216, 20–40 (2018).
Caruso, R., Lo, B. C. & Núñez, G. Host–microbiota interactions in inflammatory bowel disease. Nat. Rev. Immunol. 20, 411–426 (2020).
Article CAS PubMed Google Scholar
Wong, S. H. & Yu, J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat. Rev. Gastroenterol. Hepatol. 16, 690–704 (2019).
Article CAS PubMed Google Scholar
Jia, B., Han, X., Kim, K. H. & Jeon, C. O. Discovery and mining of enzymes from the human gut microbiome. Trends Biotechnol. 40, 240–254 (2022).
Article CAS PubMed Google Scholar
Oremland, R. S. & Capone, D. G. Use of ‘specific’ inhibitors in biogeochemistry and microbial ecology. In Advances in Microbial Ecology (ed. Marshall, K. C.) 285–383 (Springer, 1988).
Walker, A. W., Duncan, S. H., Louis, P. & Flint, H. J. Phylogeny, culturing, and metagenomics of the human gut microbiota. Trends Microbiol. 22, 267–274 (2014).
Article CAS PubMed Google Scholar
Stewart, E. J. Growing unculturable bacteria. J. Bacteriol. 194, 4151–4160 (2012).
Article CAS PubMed PubMed Central Google Scholar
Goodman, A. L. et al. Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 6, 279–289 (2010).
Jia, W., Li, H., Zhao, L. & Nicholson, J. K. Gut microbiota: a potential new territory for drug targeting. Nat. Rev. Drug. Discov. 7, 123–129 (2008).
Article CAS PubMed Google Scholar
Holmes, E. et al. Therapeutic modulation of microbiota–host metabolic interactions. Sci. Transl. Med. 4, 137rv6 (2012).
Lemon, K. P., Armitage, G. C., Relman, D. A. & Fischbach, M. A. Microbiota-targeted therapies: an ecological perspective. Sci. Transl. Med. 4, 137rv5 (2012).
Article PubMed PubMed Central Google Scholar
Schwartz, D. J., Langdon, A. E. & Dantas, G. Understanding the impact of antibiotic perturbation on the human microbiome. Genome Med. 12, 82 (2020).
Article PubMed PubMed Central Google Scholar
Ramirez, J. et al. Antibiotics as major disruptors of gut microbiota. Front. Cell. Infect. Microbiol. 10, 572912 (2020).
Article CAS PubMed PubMed Central Google Scholar
Elvers, K. T. et al. Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review. BMJ Open. 10, e035677 (2020).
Article PubMed PubMed Central Google Scholar
Zheng, D., Liwinski, T. & Elinav, E. Interaction between microbiota and immunity in health and disease. Cell Res. 30, 492–506 (2020).
Article PubMed PubMed Central Google Scholar
Burstein, D. et al. New CRISPR–Cas systems from uncultivated microbes. Nature 542, 237–241 (2017).
Article CAS PubMed Google Scholar
Ronda, C., Chen, S. P., Cabral, V., Yaung, S. J. & Wang, H. H. Metagenomic engineering of the mammalian gut microbiome in situ. Nat. Methods 16, 167–170 (2019).
Article CAS PubMed PubMed Central Google Scholar
Munck, C., Sheth, R. U., Freedberg, D. E. & Wang, H. H. Recording mobile DNA in the gut microbiota using an Escherichia coli CRISPR–Cas spacer acquisition platform. Nat. Commun. 11, 95 (2020).
Article CAS PubMed PubMed Central Google Scholar
Gibson, G. R. & Roberfroid, M. B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125, 1401–1412 (1995).
Article CAS PubMed Google Scholar
Monteagudo-Mera, A. et al. High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome. Benef. Microbes 7, 247–264 (2016).
Article CAS PubMed PubMed Central Google Scholar
Azcarate-Peril, M. A. et al. Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals. Proc. Natl Acad. Sci. 114, E367–E375 (2017).
Article CAS PubMed PubMed Central Google Scholar
Kearney, S. M., Gibbons, S. M., Erdman, S. E. & Alm, E. J. Orthogonal dietary niche enables reversible engraftment of a gut bacterial commensal. Cell Rep. 24, 1842–1851 (2018).
Article CAS PubMed PubMed Central Google Scholar
Shepherd, E. S., Deloache, W. C., Pruss, K. M., Whitaker, W. R. & Sonnenburg, J. L. An exclusive metabolic niche enables strain engraftment in the gut microbiota. Nature 557, 434–438 (2018).
Article CAS PubMed PubMed Central Google Scholar
Fuller, R. Probiotics in man and animals. J. Appl. Bacteriol. 66, 365–378 (1989).
Article CAS PubMed Google Scholar
Sperti, G. S. Probiotics (Avi Publishing Company, 1971).
Dinleyici, E. C., Eren, M., Ozen, M., Yargic, Z. A. & Vandenplas, Y. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert. Opin. Biol. Ther. 12, 395–410 (2012).
Article CAS PubMed Google Scholar
Na, X. & Kelly, C. Probiotics in Clostridium difficile infection. J. Clin. Gastroenterol. 45, S154–S158 (2011).
Article PubMed PubMed Central Google Scholar
Sánchez, B. et al. Probiotics, gut microbiota, and their influence on host health and disease. Mol. Nutr. Food Res. 61, 1600240 (2017).
Gibson, G. R. & Wang, X. Inhibitory effects of bifidobacteria on other colonic bacteria. J. Appl. Bacteriol. 77, 412–420 (1994).
Article CAS PubMed Google Scholar
Hansen, R. Bifidobacteria have come to Denmark to stay. N. Eur. Dairy. J. 51, 79–83 (1985).
Nishizawa, Y. Physiological activity of bifidobacteria. Shonika Shinryo 23, 1213–1218 (1960).
Mizutani, T. & Mitsuoka, T. Inhibitory effect of some intestinal bacteria on liver tumorigenesis in gnotobiotic C3H/HE male mice. Cancer Lett. 11, 89–95 (1980).
Article CAS PubMed Google Scholar
Howarth, G. S. & Wang, H. Role of endogenous microbiota, probiotics and their biological products in human health. Nutrients 5, 58–81 (2013).
Article CAS PubMed PubMed Central Google Scholar
Grangette, C. et al. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. Natl Acad. Sci. 102, 10321–10326 (2005).
Article CAS PubMed PubMed Central Google Scholar
Jones, M. L., Chen, H., Ouyang, W., Metz, T. & Prakash, S. Microencapsulated genetically engineered Lactobacillus plantarum 80 (pCBH1) for bile acid deconjugation and its implication in lowering cholesterol. J. Biomed. Biotechnol. 2004, 61–69 (2004).
Article PubMed PubMed Central Google Scholar
Carroll, I. M. et al. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G729–G738 (2007).
Article CAS PubMed Google Scholar
Palmer, J. D. et al. Engineered probiotic for the inhibition of Salmonella via tetrathionate-induced production of microcin H47. ACS Infect. Dis. 4, 39–45 (2018).
Article CAS PubMed Google Scholar
Dosoky, N. S., Guo, L., Chen, Z., Feigley, A. V. & Davies, S. S. Dietary fatty acids control the species of N-acyl-phosphatidylethanolamines synthesized by therapeutically modified bacteria in the intestinal tract. ACS Infect. Dis. 4, 3–13 (2018).
Article CAS PubMed Google Scholar
Bouhnik, Y. et al. Fecal recovery in humans of viable Bifidobacterium sp. ingested in fermented milk. Gastroenterology 102, 875–878 (1992).
留言 (0)